Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Agile Thrpe
AGRXCurrent price
–
Last closed
–
Company
www.agiletherapeutics.com
ISIN
US00847L1008
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
10 425 795 USD
Yield for 12 month
-100.00 %
1Y
3Y
5Y
10Y
15Y
AGRX
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. As of August 26, 2024, Agile Therapeutics, Inc. operates as a subsidiary of Exeltis USA, Inc. Address: 500 College Road East, Princeton, NJ, United States, 08540
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+19 593 000 USD
Last Year
+10 884 000 USD
Current Quarter
+5 576 000 USD
Last Quarter
+5 716 000 USD
Current Year
+10 615 000 USD
Last Year
+4 048 000 USD
Current Quarter
+4 080 000 USD
Last Quarter
+4 036 000 USD
Key Figures AGRX
1 year
3 years
5 years
10 years
EBITDA
-13 154 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-61.55 %
PEG Ratio
–
Return On Equity TTM
-1364.04 %
Wall Street Target Price
5 USD
Revenue TTM
21 569 000 USD
Book Value
-3.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1.3 %
Dividend Yield
–
Gross Profit TTM
-6 617 000 USD
Earnings per share
-1.7 USD
Diluted Eps TTM
-1.7 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-73.52 %
Dividend Analytics AGRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AGRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
11.04.2023
Dividend Date
–
Stock Valuation AGRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.9551
Enterprise Value Revenue
0.3647
Price Sales TTM
0.4834
Enterprise Value EBITDA
-0.1087
Price Book MRQ
1.785
Financials AGRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AGRX
For 52 weeks
0.2 USD
2.61 USD
50 Day MA
1.29 USD
Shares Short Prior Month
213 078
200 Day MA
1.14 USD
Short Ratio
0.28
Shares Short
222 097
Short Percent
7.5 %
BeatStart